SUMMARY Estimation with a whole-body counter of the fall in total body radioactivity due to loss of parenterally administered 59Fe has been used to measure blood loss in 17 patients with ulcerative colitis. It was shown that blood loss was related to the activity ofdisease as judged by sigmoidoscopic changes and less obviously to the extent of involvement of the colon.
Iron-deficiency states occur commonly in proctocolitis and have been shown to be due mainly to loss of blood into the gastrointestinal tract (Ormerod, 1967) . Blood loss can be quantitated by injecting intravenously red blood cells labelled with 51Cr and then measuring the amounts of radioisotope passed in the stool (Bannerman, 1957) or by chemically estimating the faecal haemoglobin content (Ebaugh and Beeken, 1959; Ormerod, 1967) . Since these methods involve the collection of all the stool passed during the period of investigation, they are impracticable for long-term outpatient studies and liable to inaccuracy in patients with severe diarrhoea, urgency of defaecation, and incontinence.
In this study we have used a technique for measuring blood loss which avoids the need for stool collection. This method is similar to that described by Price, Reizenstein, Cohn, Cronkite, and Wasserman (1961) and more recently by Holt, Mayet, Warner, and Callender (1967) , and is based on the fact that in normal men loss of iron from the body is very small, on average 06 mg per day (Finch, 1964) , or roughly the equivalent of 1 ml of blood. After the intravenous injection of radioactive iron 5"Fe, the radionuclide is mostly incorporated into circulating haemoglobin. Hence a fall in the wholebody count rate represents loss of blood. 
TECHNIQUE
Details of the procedure were explained to each patient and his permission to proceed with the investigations was obtained. Three to 5 g Ci (0.3 to 0.5 &g) of radioactive iron, "9Fe, as ferric citrate in isotonic saline', was added to 10 ml of the patient's own plasma under sterile conditions and then left at room temperature for 30 minutes to allow complete binding of the added iron by transferrin. This labelled plasma was then injected intravenously. After allowing a period of 10 days for most or all of this dose to become incorporated in the haemoglobin of the circulating red blood cells, the total body radioactivity due to "@Fe was measured in a whole-body counter.
This counter consists of a movable large-area plastic scintillation detector situated below a lightweight couch. The whole unit is surrounded by a wall of compressed powdered chalk to shield against environmental radiation (Barnaby and Smith, 1967) . The patient was counted lying prone and supine with the counter in three different positions in each case. By combination of these readings, counting efficiency can be made relatively insensitive to changes in distribution of radioactivity within the body.
The loss of "9Fe from the body was determined from the difference between the whole-body counts recorded at the beginning and end of each period of investigation. All counts were corrected for radioactive decay and changes in counting efficiency by counting appropriate "@Fe standards. Duplicate 2 ml aliquots of whole blood, taken at the time of each whole-body measurement, were lysed with saponin and counted in a well-type Nal scintillation counter' to a counting statistical accuracy of 2%. After correcting for radioactive decay of 59Fe, the specific activity of whole blood (counts/sec/ml), averaged over the period between whole-body counts, was determined. This value was used to convert the loss of wholebody counts to an equivalent volume of blood and it was therefore necessary to relate the efficiency of counting a 2 ml blood sample in the NaI counter to that of counting 59Fe in patients in the whole-body counter. The efficiency with which 59Fe could be counted in patients of various sizes was determined by means of a series of phantoms containing a solution of '9Fe. These efficiencies were measured relative to that of a 10 ml reference source counted at the centre of the whole-body counter. The effliciency of counting the 2 ml blood samples was also related to this reference so that whole-body and blood counts could be compared. In practice, 10 ml and 2 ml aliquots of a 59Fe solution were used to calibrate the whole-body counter and NaI counter, respectively, whenever counting was performed.
In any interval between whole-body counts, the fall in whole-body count rate (A) was converted to an equivalent blood volume (V) by means of the formula:
where fl and f2 were, respectively, the efficiency of counting 59Fe in the patient and the efficiency of counting a 2 ml blood sample in relation to that of oounting the 10 ml reference source. B was the mean count rate per ml of blood during the period in which the fall in wholebody count rate was A.
ACCURACY OF THE TECHNIQUE Since blood loss is estimated indirectly by the difference between two wholebody counts, the accuracy of the method is critically dependent on the precision with which these can be made. For blood losses of less than a litre, the only significant inaccuracy results from the difficulty of reproducing exactly the patient's counting position on different occasions. In 13 patients on whom two separate counts were made on the same occasion, the difference between two counts had an average value of P1 % of the mean of the two counts. In individuals, this value had a standard deviation of 1.0%. Thus when considering blood loss from the total blood volume, the majority of errors due to this factor will be less than 2.1 % of the total blood volume (ie, about 100 ml). Although an error arising from the calibration factor f1 becomes significant with blood losses over a litre, losses of this magnitude were not encountered in this investigation. Three further studies were undertaken to check the accuracy of the method. In the first, the whole-body counter was used to measure known volumes of blood withdrawn from three patients with polycythaemia, one patient with haemochromatosis, and one normal subject. When the volumes of blood removed were plotted against the volumes determined by this technique, the correlation coefficient was 0.96 ( Fig. 1 ). The differences between the actual volumes removed and those measured by wholebody counting ranged from +67 to -66 ml, with a mean value of -4 ml. In three control subjects, all male, who were not suffering from any gastrointestinal disorder, blood loss was studied over a period of four to eight weeks. The results obtained with the whole-body counter, corrected for blood samples removed, were expressed as the mean daily loss and were 1.9, 2. 1, and 2.7 ml respectively. These values are within the range of normal estimated by other methods (Roche, Perez-Gimenez, Layrisse, and Di Prisco, 1957; Ebaugh and Beeken, 1959) .
The third study consisted of a comparison of the measurement of blood loss over one week using the whole-body counter with that obtained by determination of the faecal excretion of parenterally administered '1Cr over the same period. For this purpose, eight patients with colitis were given red blood cells labelled with 30 g Ci of 51Cr (as sodium chromate) 10 days after a dose of "9Fe. After a further 24 hours, stools were collected for one week. There was a good correlation between the results obtained with the two methods (Table I) . Blood loss was measured in 17 adult patients with ulcerative colitis, of whom six were premenopausal females and 11 were males. In seven, the disease was extensive, involving colon proximal to the splenic flexure; in one, the descending colon, rectum, and sigmoid were affected and nine had proctosigmoiditis. All had had a recent exacerbation of their colitis and had started treatment for this at least 10 days before the measurement of blood loss was begun.
Measurement of total body radioactivity was repeated at weekly and fortnightly intervals over a period of four to eight weeks. Before each measurement a blood sample was taken to measure the radioactivity. Correction was made for these blood samples and for others removed for laboratory investigations in the final estimation of blood loss. Any phase of study in which non-alimentary blood loss occurred was excluded from the results.
The activity of the colitis at the time of the whole-body counting was assessed by sigmoidoscopic appearances graded according to the criteria of Baron, Connell, and Lennard-Jones (1964) . Grade I ('normal') constituted the normal vascular pattern, grade II ('inactive') a nonfriable mucosa without vascular pattern, grade III ('friable') a mucosa with contact but no spontaneous bleeding, and grade IV ('spontaneous bleeding') a mucosa which bled ahead of the sigmoidoscope. Grades I and II are described as 'non-haemorrhagic' and grades III and IV as 'haemorrhagic'. The patients' observations on the presence or absence of blood in the stools were also recorded. Figure 2 relates blood loss to sigmoidoscopic appearance, where this appearance was constant at the beginning and end of the weekly or fortnightly interval studied. Weekly losses ranged from zero to just over 600 ml. There was a rough correlation between the degree of blood loss and the sigmoidoscopic grading in that most patients with a haemorrhagic mucosa (grades III and IV) were losing more than 200 ml of blood per week, whereas in those with a non-haemorrhagic mucosa (grades I and II) the blood loss was usually less than 200 ml per week. In half of the 28 non-haemorrhagic periods studied, blood loss exceeded 50 ml per week and in four instances exceeded 200 ml per week.
RESULTS

CORRELATION OF BLOOD LOSS WITH SIGMOIDOSCOPIC APPEARANCES
CORRELATION OF BLOOD LOSS WITH EXTENT OF
COLITIS From the results summarized in Fig. 2, it was not possible to demonstrate a clear correlation between blood loss and the extent of colitis. This diagram excludes blood losses in periods in which the signoidoscopic appearance changed during the week or fortnight of observation. When these periods Figure 3 relates the measured blood loss to the patients' observations of blood in the stools. It shows that the patients noticed blood in the stools in all except three of the 20 periods when the loss exceeded 200 ml per week. Many patients losing 50 to 150 ml of blood per week, however, did not notice the presence of blood in the stools. Thus patients' statements that there is no blood in their stools do not mean that blood loss is insignificant. CALCULATION OF TOTAL IRON LOSS From the blood loss measurements, the iron loss was calculated and these results are shown in Table II . Over a period of four to eight weeks the total iron loss varied greatly from 30 mg in one patient to 1.3 g in another. Three patients lost more than 0.5 g of iron over this period in spite of conventional medical treatment for the colitis.
DISCUSSION
The present study is the first reported where the whole-body counting technique, in which stool collections are not required, has been used to measure blood loss in colitis. The difficulty of obtaining complete faecal collections in clinical work has been emphasized by Callender, Witts, Warner, and Oliver (1966) and this difficulty applies particularly in colitis.
There has been only one previous critical assessment of blood loss measurements using a wholebody counter, that of Holt et al (1967) . These authors made 29 measurements of known blood loss between 395 and 520 ml with a mean error of -12 % and a range from -60 to + 50%. In the present investigation, the mean error of eight measurements over a similar range of blood loss (400 to 500 ml) has been -2% with a range of -14 to +16% (in absolute terms, a mean error of -7 ml with a range of -66 to +67 ml). The principal source of error in the present study arises from minor variations in the patient's counting position on different occasions. With careful positioning of the patients, the error of a single blood loss measurement can be reduced to less than 100 ml in most cases. A second source of inaccuracy arises from the error associated with the calibration factor fl, which is a measure of the efficiency of counting 59Fe in a given patient relative to the reference standard. This error is about 5 % of the blood-loss value.
The accuracy of our method has been verified by simultaneous determination of blood loss using the whole-body counter and 51Cr technique in eight patients. The differences in blood loss estimations between the two methods were, with one exception, less than 50 ml and therefore well within the estimated range of error of the whole-body counting technique (Table I ). The tendency for the faecal 51Cr method to produce lower values for blood loss probably reflects the difficulty of achieving complete stool collections in patients with severe colitis. Estimation of blood loss in control subjects has also been used to evaluate the accuracy of the method.
In previous studies with the whole-body counter (Price, Forsyth, Cohn, and Cronkite, 1964; Holt et al, 1967) , blood loss was calculated from the percentage change in 59Fe retention on the assumption that this was equivalent to the same percentage change of blood volume. For this calculation an accurate assessment of total blood volume was essential. Holt et al (1967) calculated the blood volume in control subjects and iron-deficient patients using a value of 65.6 ml per kilogram of body weight (Wasserman, Yoh, and Rashkoff, 1951) . In more recent reports, the normal blood volume has averaged 75 ml per kilogram in men and 66 ml per kilogram in women (Gregersen and Rawson, 1959; Twigg, Nakayama, and Goodwin, 1958) . It has also been shown that blood volume correlates poorly with body weight as the sole physical parameter and can be predicted more accurately on the basis of a formula including both height and weight (Nadler, Hidalgo, and Block, 1962) . The present technique, in which blood loss is estimated directly by measuring the mean concentration of 69Fe in the blood and relating this to the fall in whole-body counts, does not require a knowledge of the blood volume. In this technique it is also unnecessary to measure the red cell utilization of 60Fe.
A disadvantage of the whole-body counting technique is the delay (seven to 10 days) before blood loss can be measured. This delay is necessary because soon after injection radioactivity is localized in the bone marrow and later the 59Fe in the red cell mass increases rapidly as the iron is released from the marrow. These changes lead to variation in counting efficiency and to errors in estimating the average concentration of radioiron in the blood (Sargent, 1962) . Because of this delay, many of the patients in this study were already improving with medical treatment when measurements were begun. Thus the blood losses in the most severe phases of colitis probably exceeded those measured in this study.
The volumes of blood lost in the present study ranged from 0 to 88 ml per 24 hours, these figures representing the average daily loss over weekly or fortnightly periods. This wide range compares very closely with that of 1 to 89 ml per 24 hours (the average over four days) obtained by Ormerod (1967) using a chemical method of measuring blood loss in the only previous quantitative study of bleeding in active ulcerative colitis. As might be expected the amount of blood lost was influenced both by the activity of the inflammation and the area of mucosa inflamed.
In most (71 %) of the phases in this study when bleeding exceeded 200 ml per week, the rectal mucosa appeared haemorrhagic on sigmoidoscopy. Of greater interest was the finding that where the mucosa was not haemorrhagic blood loss of more than 50 ml per week was common and on four occasions exceeded 200 ml per week. Blood losses of 50 to 150 ml per week were also measured when patients observed no blood in the stools. These findings are in keeping with the observations of Beal, Skyring, McRae, and Firkin (1963) that on several days two of five patients with colitis in remission had a faecal blood loss in excess of 25 ml per 24 hours.
The present study has shown that iron losses of the order of 0.5 to 1.3 g may occur over the course of several weeks in an attack of colitis. Since the total iron content of a normal adult averages 5 g, the importance of adequate iron replacement in colitis is evident. In view of the possible impairment of iron absorption in colitis suggested by recent studies (Ormerod, 1968) and the fact that oral iron sometimes aggravates the symptoms, parenteral iron therapy is often the best means of correcting the iron losses.
